← Leaderboards
Shannon Marie Miller
Scripps Research Institute, The
$2,714,903
Attributed
$2,714,903
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$2,714,903 · 3
By mechanism
DP2$1,638,033 · 1
P01$570,870 · 1
R21$506,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Howard C Hang$15,699,389
- Dale L Boger$41,942,040
- Charles W Hespen$308,174
- Jonathan Kyle Pokorski$2,075,618
- Nicole Franziska Steinmetz$15,228,645
Others in their field
Other Rising Stars on “Genes”
- Mari Ostendorf · University Of Washington$51,931,230
- Suma Babu · Massachusetts General Hospital$28,791,731
- Sabrina Paganoni · Massachusetts General Hospital$28,791,731
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Bridget Murphy · Broad Institute, Inc.$23,600,775
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
Research focus
GenesClustered Regularly Interspaced Short Palindromic RepeatsGenome EditingEngineeringProteinsSafetyVectorComplexSiteResponseTechnologyToxic EffectSpecificityIn VivoDelivery VehicleCellsGenomicsImmunogenicityDirected Molecular EvolutionSuccessGene CorrectionGenetic DiseasesCell Culture TechniquesEukaryotic Cell
Grant awards (4)
Next Generation IgH-reprogramming for in vivo delivery$570,870
P01 · FY2025 · HL · contact PI
Development of potent and safe CRISPR tools for in vivo gene editing using directed evolution$230,000
R21 · FY2025 · EB · contact PI
Developing a CRISPR-free mammalian recombineering system$1,638,033
DP2 · FY2024 · GM · contact PI
Development of potent and safe CRISPR tools for in vivo gene editing using directed evolution$276,000
R21 · FY2024 · EB · contact PI